BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, January 8, 2026
See today's BioWorld MedTech
Home
» Fractyl offers mechanism of action results, as it aims for intestinal resurfacing U.S. pivotal trial in 2020
To read the full story,
subscribe
or
sign in
.
Fractyl offers mechanism of action results, as it aims for intestinal resurfacing U.S. pivotal trial in 2020
March 30, 2020
By
Stacy Lawrence
Fractyl Laboratories Inc. has released data from a mixed meal tolerance study that shows its procedure for resurfacing the duodenal mucosa improves fasting blood glucose and reduces liver fat.
BioWorld MedTech
Clinical
Diabetes
Endocrine/metabolic